Lymphoma Assessment Package
Extensive expertise in lymph node biopsy assessment and lymphoma classification
Nationally renowned board certified hematopathologists
Minimal tissue required
Fast TAT 7-10 days
Direct access to expert hematopathologists
sïParadigm’s multidisciplinary team of experts with extensive training in lymphomas is committed to maintaining proficient testing, ensuring proper
Risk Stratification, Disease Prognosis, and Targeted Treatment
Therapeutic approaches in patients with newly diagnosed diffuse large B-cell lymphoma
Accurate diagnosis and subtype classification of lymphomas depend on a multimodal approach, including clinical presentation, careful morphologic review, immunohistochemistry, cytogenetics, flowcytometry, and molecular diagnosis.
As Recommended By Major Clinical Practice Guidelines
Incisional or Excisional Lymph Node Biopsy is recommended to establish the diagnosis of lymphomas.
Combining Core Needle Biopsy and Fine-Needle Aspiration, along with suitable ancillary tests, is sufficient for differential diagnosis.
An accurate pathologic diagnosis of the subtype is the most important first step in the management of lymphomas
Excisional Biopsy
0.5 cm x 0.5 cm
x 0.5 cm in RPMI
Place the rest
immediately in formalin
Core Needle biopsy
1 Core in RPMI
Place 6-8 cores in
formalin
Lymphoma Assessment Package
Barry Kaplan, MD, PhD
Oncologist/Hematologist, Queens Medical Assoc.
With core values rooted in service and integrity, our leadership team sets the bar high.
We consistently strive to set the model for exactly how a reference laboratory should engage with both physicians and patients.
siParadigm is accredited by CLIA (Clinical Laboratory Improvement Amendments) and certified by CAP (College of American Pathologists).
We also hold select state licensure where required.
Contact Us
+1 888 599 LABS
Customer Service
cs@siparadigm.com
Have Questions or Concerns?
feedback@siparadigm.com
Unless otherwise noted, all content is CC-BY 2020 by siParadigm, LLC.